ITB-Iplus/GDF-MED/2024/3
27 November 2024 – Geneva, Switzerland – On behalf of Stop TB Partnership’s Global Drug Facility (GDF), i+solutions, the GDF-contracted procurement agent, invites all eligible suppliers to submit bids for: ITB-Iplus/GDF-MED/2024/3 for bedaquiline 100mg and 20mg tablets, 3HP tablets (rifapentine/isoniazid 300mg/300mg tablets), rifapentine 300mg tablets and rifapentine 150mg dispersible tablets for the period from 1st […]